Astaxanthin increases choroidal blood flow velocity

Graefe's Archive for Clinical and Experimental Ophthalmology

Volumn 250, Issue 2, 2012, Pages 239-245

  Saito, Michiyuki ^a   Yoshida, Kazuhiko ^a   Saito, Wataru ^a   Fujiya, Akio ^a   Ohgami, Kazuhiro ^a   Kitaichi, Nobuyoshi ^b   Tsukahara, Hiroki ^c   Ishida, Susumu ^a   Ohno, Shigeaki ^a  

^a HOKKAIDO UNIVERSITY   (Japan)

^b HEALTH SCIENCES UNIVERSITY OF HOKKAIDO   (Japan)

^c FUJI CHEMICAL INDUSTRIES LTD   (Japan)

Author keywords

Astaxanthin; Choroidal blood flow velocity; Laser speckle flowgraphy

Indexed keywords

ASTARILE; ASTAXANTHIN; PLACEBO; UNCLASSIFIED DRUG;

ABSENCE OF SIDE EFFECTS; ADULT; ADVERSE OUTCOME; ARTICLE; CHOROID VASCULARIZATION; CLINICAL EFFECTIVENESS; CLINICAL EVALUATION; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; DRUG SAFETY; EYE BLOOD FLOW; FEMALE; HEMODYNAMIC MONITORING; HUMAN; HUMAN EXPERIMENT; INTRAOCULAR PRESSURE; MALE; NORMAL HUMAN; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REFRACTION ERROR; TREATMENT DURATION; VISUAL ACUITY;

ADMINISTRATION, ORAL; ADULT; ANTI-INFLAMMATORY AGENTS; ANTIOXIDANTS; BLOOD FLOW VELOCITY; CAPSULES; CHOROID; DOUBLE-BLIND METHOD; FEMALE; HEMODYNAMICS; HUMANS; INTRAOCULAR PRESSURE; LASER-DOPPLER FLOWMETRY; MALE; REGIONAL BLOOD FLOW; XANTHOPHYLLS;

EID: 84857374191     PISSN: 0721832X     EISSN: 1435702X     Source Type: Journal    
DOI: 10.1007/s00417-011-1843-1     Document Type: Article

References (26)

1. Esterbauer H, Jurgens G, Quehenberger O, Koller E (1987) Autoxidation of human low density lipoprotein: loss of polyunsaturated fatty acids and vitamin E and generation of aldehydes. J Lipid Res 28:495-509 (Pubitemid 17116184)
2. Tanaka T, Makita H, Ohnishi M, Mori H, Satoh K, Hara A (1995) Chemoprevention of rat oral carcinogenesis by naturally occurring xanthophylls, astaxanthin and canthaxanthin. Cancer Res 55:4059-4064
3. Wang X, Willen R, Wadstrom T (2000) Astaxanthin-rich algal meal and vitamin C inhibit Helicobacter pylori infection in BALB/cA mice. Antimicrob Agents Chemother 44:2452-2457 (Pubitemid 30650894)
4. Li W, Hellsten A, Jacobsson LS, Blomqvist HM, Olsson AG, Yuan XM (2004) Alpha-tocopherol and astaxanthin decrease macrophage infiltration, apoptosis and vulnerability in atheroma of hyperlipidaemic rabbits. J Mol Cell Cardiol 37:969-978 (Pubitemid 39446822)
5. Ohgami K, Shiratori K, Kotake S, Nishida T, Mizuki N, Yazawa K, Ohno S (2003) Effects of astaxanthin on lipopolysaccharideinduced inflammation in vitro and in vivo. Invest Ophthalmol Vis Sci 44:2694-2701 (Pubitemid 36618432)
6. Uchiyama K, Naito Y, Hasegawa G, Nakamura N, Takahashi J, Yoshikawa T (2002) Astaxanthin protects beta-cells against glucose toxicity in diabetic db/db mice. Redox Rep 7:290-293 (Pubitemid 36032916)
7. Naito Y, Uchiyama K, Aoi W, Hasegawa G, Nakamura N, Yoshida N, Maoka T, Takahashi J, Yoshikawa T (2004) Prevention of diabetic nephropathy by treatment with astaxanthin in diabetic db/db mice. Biofactors 20:49-59 (Pubitemid 38586209)
8. Miyawaki H, Takahashi J, Tsukahara H, Takehara I (2008) Effects of astaxanthin on human blood rheology. J Clin Biochem Nutr 43:69-74
9. Hussein G, Nakamura M, Zhao Q, Iguchi T, Goto H, Sankawa U, Watanabe H (2005) Antihypertensive potential and mechanism of action of astaxanthin: II. Vascular reactivity and hemorheology in spontaneously hypertensive rats. Biol Pharm Bull 28:967-971 (Pubitemid 40880298)
10. Hirose S, Saito W, Yoshida K, Saito M, Dong Z, Namba K, Satoh H, Ohno S (2008) Elevated choroidal blood flow velocity during systemic corticosteroid therapy in Vogt-Koyanagi-Harada disease. Acta Ophthalmol 86:902-907
11. Grunwald JE, Metelitsina TI, Dupont JC, Ying GS, Maguire MG (2005) Reduced foveolar choroidal blood flow in eyes with increasing AMD severity. Invest Ophthalmol Vis Sci 46:1033-1038 (Pubitemid 41321042)
12. Ohi Y, Kitamura A, Tsukahara H, Takahashi J, Itakura H (2011) The supplementation inquest of astaxanthin on blood kinetics. Journal of Clinical Therapeutics & Medicines 27: [Epub ahead of print]
13. Tamaki Y, Araie M, Kawamoto E, Eguchi S, Fujii H (1995) Noncontact, two-dimensional measurement of tissue circulation in choroid and optic nerve head using laser speckle phenomenon. Exp Eye Res 60:373-383
14. Isono H, Kishi S, Kimura Y, Hagiwara N, Konishi N, Fujii H (2003) Observation of choroidal circulation using index of erythrocytic velocity. Arch Ophthalmol 121:225-231 (Pubitemid 36184036)
15. Takayama J, Mayama C, Mishima A, Nagahara M, Tomidokoro A, Araie M (2009) Topical phenylephrine decreases blood velocity in the optic nerve head and increases resistive index in the retinal arteries. Eye Lond 23:827-834
16. Tamaki Y, Araie M, Kawamoto E, Eguchi S, Fujii H (1994) Noncontact, two-dimensional measurement of retinal microcirculation using laser speckle phenomenon. Invest Ophthalmol Vis Sci 35:3825-3834 (Pubitemid 24334539)
17. Riva CE, Titze P, Hero M, Petrig BL (1997) Effect of acute decreases of perfusion pressure on choroidal blood flow in humans. Invest Ophthalmol Vis Sci 38:1752-1760 (Pubitemid 27382340)
18. Sugiyama T, Utsumi T, Azuma I, Fujii H (1996) Measurement of optic nerve head circulation: comparison of laser speckle and hydrogen clearance methods. Jpn J Ophthalmol 40:339-343 (Pubitemid 26388368)
19. Ishii K, Tomidokoro A, Nagahara M, Tamaki Y, Kanno M, Fukaya Y, Araie M (2001) Effects of topical latanoprost on optic nerve head circulation in rabbits, monkeys, and humans. Invest Ophthalmol Vis Sci 42:2957-2963 (Pubitemid 33035296)
20. Hayashi N, Ikemura T, Someya N (2011) Effects of dynamic exercise and its intensity on ocular blood flow in humans. Eur J Appl Physiol 111:2601-2606
21. Alm A, BillA (1973) Ocular and optic nerve blood flow at normal and increased intraocular pressures in monkeys (Macaca irus): a study with radioactively labelled microspheres including flow determinations in brain and some other tissues. Exp Eye Res 15:15-29
22. Schatz H (1994) Fluorescein angiography: basic principles and interpretation. In: Ryan SJ (ed) Retina.Mosby, St. Louis, pp 911-984
23. Iwamoto T, Hosoda K, Hirano R, Kurata H, Matsumoto A, Miki W, Kamiyama M, Itakura H, Yamamoto S, Kondo K (2000) Inhibition of low-density lipoprotein oxidation by astaxanthin. J Atheroscler Thromb 7:216-222
24. Osterlie M, Bjerkeng B, Liaaen-Jensen S (2000) Plasma appearance and distribution of astaxanthin E/Z and R/S isomers in plasma lipoproteins of men after single dose administration of astaxanthin. J Nutr Biochem 11:482-490
25. Coral-Hinostroza GN, Ytrestoyl T, Ruyter B, Bjerkeng B (2004) Plasma appearance of unesterified astaxanthin geometrical E/Z and optical R/S isomers in men given single doses of a mixture of optical 3 and 3'R/S isomers of astaxanthin fatty acyl diesters. Comp Biochem Physiol C Toxicol Pharmacol 139:99-110 (Pubitemid 39535793)
26. Ellis PD (2010) The essential guide to effect sizes: statistical power, meta-analysis, and the interpretation of research results. Cambridge University Press, Cambridge UK